Insmed Incorporated
Status: Publicly traded
Direct answer
Insmed Incorporated is publicly traded on NASDAQ under the ticker INSM.
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed...
Can you invest in Insmed Incorporated?
Yes. Insmed Incorporated trades publicly on NASDAQ as INSM.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Insmed Incorporated
Detailed equity research is provided by MarketSnap.